{"nct_id":"NCT02235740","title":"A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)","status":"TERMINATED","status_verified_date":"2016-05","start_date":"2014-11","start_date_type":null,"primary_completion_date":"2015-10","primary_completion_date_type":"ACTUAL","completion_date":"2015-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}